• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上调的 KDM4B 通过激活自噬促进前列腺癌细胞增殖。

Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.

机构信息

Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.

出版信息

J Cell Physiol. 2020 Mar;235(3):2129-2138. doi: 10.1002/jcp.29117. Epub 2019 Aug 29.

DOI:10.1002/jcp.29117
PMID:31468537
Abstract

Castration-resistant prostate cancer (CRPC) causes most of the deaths in patients with prostate cancer (PCa). The androgen receptor (AR) axis plays an important role in castration resistance. Emerging studies showed that the lysine demethylase KDM4B is a key molecule in AR signaling and turnover, and autophagy plays an important role in CRPC. However, little is known about whether KDM4B promotes CRPC progression by regulating autophagy. Here we used an androgen-independent LNCaP (LNCaP-AI) cell line to assay aberrant KDM4B expression using qPCR and western blot analysis and investigated the function of KDM4B in regulating cell proliferation. We found that KDM4B was markedly increased in LNCaP-AI cells compared with LNCaP cells. KDM4B level was significantly correlated with the Gleason score in PCa tissues. In vitro, KDM4B overexpression in CRPC cells promoted cell proliferation, whereas knockdown of KDM4B significantly inhibited cell proliferation. Upregulated KDM4B contributed to activate Wnt/β-catenin signaling and autophagy. Moreover, KDM4B activated autophagy by regulating the Wnt/β-catenin signaling. Finally, we demonstrated that autophagy inhibition attenuated KDM4B-induced CRPC cell proliferation. Our results provided novel insights into the function of KDM4B-driven CRPC development and indicated that KDM4B may be served as a potential target for CRPC therapy.

摘要

去势抵抗性前列腺癌(CRPC)是导致前列腺癌(PCa)患者死亡的主要原因。雄激素受体(AR)轴在去势抵抗中起重要作用。新兴研究表明,赖氨酸去甲基酶 KDM4B 是 AR 信号转导和周转的关键分子,自噬在 CRPC 中起重要作用。然而,目前尚不清楚 KDM4B 是否通过调节自噬来促进 CRPC 的进展。在这里,我们使用雄激素非依赖性 LNCaP(LNCaP-AI)细胞系通过 qPCR 和 Western blot 分析检测异常 KDM4B 表达,并研究了 KDM4B 在调节细胞增殖中的功能。我们发现,与 LNCaP 细胞相比,LNCaP-AI 细胞中 KDM4B 明显增加。KDM4B 水平与 PCa 组织中的 Gleason 评分显著相关。在体外,CRPC 细胞中 KDM4B 的过表达促进了细胞增殖,而 KDM4B 的敲低则显著抑制了细胞增殖。上调的 KDM4B 有助于激活 Wnt/β-catenin 信号和自噬。此外,KDM4B 通过调节 Wnt/β-catenin 信号来激活自噬。最后,我们证明了自噬抑制减弱了 KDM4B 诱导的 CRPC 细胞增殖。我们的研究结果为 KDM4B 驱动的 CRPC 发展的功能提供了新的见解,并表明 KDM4B 可能作为 CRPC 治疗的潜在靶点。

相似文献

1
Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.上调的 KDM4B 通过激活自噬促进前列腺癌细胞增殖。
J Cell Physiol. 2020 Mar;235(3):2129-2138. doi: 10.1002/jcp.29117. Epub 2019 Aug 29.
2
Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.靶向 KDM4B 以激活 c-Myc 调节的代谢,抑制去势抵抗性前列腺癌的肿瘤生长。
Theranostics. 2021 Jun 26;11(16):7779-7796. doi: 10.7150/thno.58729. eCollection 2021.
3
Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.组蛋白赖氨酸去甲基化酶 KDM4B 调控雄激素受体的可变剪接以响应雄激素剥夺。
Nucleic Acids Res. 2019 Dec 16;47(22):11623-11636. doi: 10.1093/nar/gkz1004.
4
Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.靶向组蛋白赖氨酸去甲基化酶 KDM4B 治疗可阻断去势抵抗性前列腺癌的生长。
Biomed Pharmacother. 2023 Feb;158:114077. doi: 10.1016/j.biopha.2022.114077. Epub 2022 Dec 7.
5
PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.PRKAR2B 通过激活 Wnt/β-catenin 并诱导上皮-间充质转化促进前列腺癌转移。
J Cell Biochem. 2018 Sep;119(9):7319-7327. doi: 10.1002/jcb.27030. Epub 2018 May 15.
6
c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.c-MYC在神经内分泌分化过程以及去势抵抗性前列腺癌中驱动组蛋白去甲基化酶PHF8。
Oncotarget. 2016 Nov 15;7(46):75585-75602. doi: 10.18632/oncotarget.12310.
7
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.接受雄激素剥夺治疗的晚期前列腺癌的下一代测序
Eur Urol. 2014 Jul;66(1):32-9. doi: 10.1016/j.eururo.2013.08.011. Epub 2013 Aug 14.
8
Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.靶向 KDM4B-AR-c-Myc 轴可提高晚期前列腺癌对雄激素受体靶向治疗的敏感性。
J Pathol. 2020 Oct;252(2):101-113. doi: 10.1002/path.5495. Epub 2020 Aug 28.
9
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.天然产物杨梅素是一种泛 KDM4 抑制剂,其与聚乳酸-羟基乙酸共聚物制剂联合使用可有效靶向治疗去势抵抗性前列腺癌。
J Biomed Sci. 2022 May 9;29(1):29. doi: 10.1186/s12929-022-00812-3.
10
Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.脂质运载蛋白2的过表达通过提高雄激素受体转录活性促进去势抵抗性前列腺癌的进展。
Oncotarget. 2016 Sep 27;7(39):64309-64317. doi: 10.18632/oncotarget.11790.

引用本文的文献

1
Anti-tumor activity of CDYL2b in prostate cancer.CDYL2b在前列腺癌中的抗肿瘤活性。
Cancer Lett. 2025 Aug 12;632:217987. doi: 10.1016/j.canlet.2025.217987.
2
Autophagy: The convergence point of aging and cancer.自噬:衰老与癌症的交汇点。
Biochem Biophys Rep. 2025 Mar 26;42:101986. doi: 10.1016/j.bbrep.2025.101986. eCollection 2025 Jun.
3
Histone demethylases in autophagy and inflammation.自噬与炎症中的组蛋白去甲基化酶
Cell Commun Signal. 2025 Jan 13;23(1):24. doi: 10.1186/s12964-024-02006-w.
4
Yam Carbon Dots Promote Bone Defect Repair by Modulating Histone Demethylase 4B.山药碳点通过调节组蛋白去甲基化酶 4B 促进骨缺损修复。
Int J Nanomedicine. 2024 Oct 16;19:10415-10434. doi: 10.2147/IJN.S477587. eCollection 2024.
5
Gene Expression Regulation and the Signal Transduction of Programmed Cell Death.基因表达调控与程序性细胞死亡的信号转导
Curr Issues Mol Biol. 2024 Sep 16;46(9):10264-10298. doi: 10.3390/cimb46090612.
6
The emerging roles of histone demethylases in cancers.组蛋白去甲基化酶在癌症中的新兴作用。
Cancer Metastasis Rev. 2024 Jun;43(2):795-821. doi: 10.1007/s10555-023-10160-9. Epub 2024 Jan 16.
7
Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.JMJD2B表观遗传调节因子的甲基化对其共激活ETV1和JUN转录因子的能力有不同影响。
Int J Biochem Mol Biol. 2023 Dec 15;14(6):101-115. eCollection 2023.
8
KDM4B: A promising oncology therapeutic target.KDM4B:一种有前景的肿瘤治疗靶标。
Cancer Sci. 2024 Jan;115(1):8-16. doi: 10.1111/cas.16005. Epub 2023 Nov 3.
9
MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy.MFAP2 通过自噬激活 Wnt/β-catenin 信号通路促进口腔鳞状细胞癌的进展。
Acta Biochim Biophys Sin (Shanghai). 2023 Aug 17;55(9):1445-1455. doi: 10.3724/abbs.2023079.
10
siRNA-mediated stathmin1 silencing inhibits proliferation of prostate carcinoma cell line.小干扰RNA介导的Stathmin1基因沉默抑制前列腺癌细胞系的增殖。
Turk J Biol. 2022 May 31;46(3):239-250. doi: 10.55730/1300-0152.2612. eCollection 2022.